経口抗糖尿病薬の世界市場:販売動向2018

【英語タイトル】Global Oral Antidiabetic Drugs Sales Market Report 2018

QYResearchが出版した調査資料(QYR80709699)・商品コード:QYR80709699
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:118
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、経口抗糖尿病薬の世界市場について調査・分析し、経口抗糖尿病薬のメーカー別販売量、市場シェア分析、種類別販売分析(スルホニルウレア、ビグアニド、メグリチニド、α-グルコシダーゼ阻害剤、その他)、用途別販売分析(病院、診療所、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、経口抗糖尿病薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・経口抗糖尿病薬市場概要
・経口抗糖尿病薬のメーカー別販売量・メーカー別シェア
・経口抗糖尿病薬の世界市場:種類別販売量(スルホニルウレア、ビグアニド、メグリチニド、α-グルコシダーゼ阻害剤、その他)
・経口抗糖尿病薬の世界市場:用途別販売量(病院、診療所、その他)
・経口抗糖尿病薬の世界市場:地域別販売量・市場シェア
・経口抗糖尿病薬の米国市場規模
・経口抗糖尿病薬の中国市場規模
・経口抗糖尿病薬の欧州市場規模
・経口抗糖尿病薬の日本市場規模
・経口抗糖尿病薬の東南アジア市場規模
・経口抗糖尿病薬のインド市場規模
・経口抗糖尿病薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・経口抗糖尿病薬のコスト分析・価格動向
・経口抗糖尿病薬の産業チェーン(サプライチェーン分析)
・経口抗糖尿病薬のマーケティング戦略・販売チャネル、流通業者
・経口抗糖尿病薬市場への影響要因分析
・経口抗糖尿病薬の世界市場予測
・経口抗糖尿病薬の米国市場予測
・経口抗糖尿病薬の中国市場予測
・経口抗糖尿病薬の欧州市場予測
・経口抗糖尿病薬の日本市場予測
・経口抗糖尿病薬の東南アジア市場予測
・経口抗糖尿病薬のインド市場予測
・経口抗糖尿病薬の種類別世界市場予測(スルホニルウレア、ビグアニド、メグリチニド、α-グルコシダーゼ阻害剤、その他)
・経口抗糖尿病薬の用途別世界市場予測(病院、診療所、その他)
...
【レポートの概要】

This report studies the global Oral Antidiabetic Drugs market status and forecast, categorizes the global Oral Antidiabetic Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
The global Oral Antidiabetic Drugs market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major players covered in this report
Eli Lilly
Merck
Pfizer
Abbott
Biocon
Sanofi
Sunpharma
Novartis
Novo Nordisk
Boehringer Ingelheim
Takeda Pharmaceuticals
Oramed Pharmaceuticals
Jiangsu Wanbang
Nanjing Xinbai

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Sulfonylureas
Biguanides
Meglitinides
Alpha-glucosidase Inhibitors
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Clinics
Others

The study objectives of this report are:
To analyze and study the global Oral Antidiabetic Drugs sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Oral Antidiabetic Drugs players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oral Antidiabetic Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Oral Antidiabetic Drugs Manufacturers
Oral Antidiabetic Drugs Distributors/Traders/Wholesalers
Oral Antidiabetic Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Oral Antidiabetic Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Oral Antidiabetic Drugs Sales Market Report 2018
1 Oral Antidiabetic Drugs Market Overview
1.1 Product Overview and Scope of Oral Antidiabetic Drugs
1.2 Classification of Oral Antidiabetic Drugs by Product Category
1.2.1 Global Oral Antidiabetic Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Oral Antidiabetic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Sulfonylureas
1.2.4 Biguanides
1.2.5 Meglitinides
1.2.6 Alpha-glucosidase Inhibitors
1.2.7 Others
1.3 Global Oral Antidiabetic Drugs Market by Application/End Users
1.3.1 Global Oral Antidiabetic Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Global Oral Antidiabetic Drugs Market by Region
1.4.1 Global Oral Antidiabetic Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Oral Antidiabetic Drugs Status and Prospect (2013-2025)
1.4.3 Europe Oral Antidiabetic Drugs Status and Prospect (2013-2025)
1.4.4 China Oral Antidiabetic Drugs Status and Prospect (2013-2025)
1.4.5 Japan Oral Antidiabetic Drugs Status and Prospect (2013-2025)
1.4.6 Southeast Asia Oral Antidiabetic Drugs Status and Prospect (2013-2025)
1.4.7 India Oral Antidiabetic Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Oral Antidiabetic Drugs (2013-2025)
1.5.1 Global Oral Antidiabetic Drugs Sales and Growth Rate (2013-2025)
1.5.2 Global Oral Antidiabetic Drugs Revenue and Growth Rate (2013-2025)

2 Global Oral Antidiabetic Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Oral Antidiabetic Drugs Market Competition by Players/Suppliers
2.1.1 Global Oral Antidiabetic Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Oral Antidiabetic Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Oral Antidiabetic Drugs (Volume and Value) by Type
2.2.1 Global Oral Antidiabetic Drugs Sales and Market Share by Type (2013-2018)
2.2.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Oral Antidiabetic Drugs (Volume and Value) by Region
2.3.1 Global Oral Antidiabetic Drugs Sales and Market Share by Region (2013-2018)
2.3.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Oral Antidiabetic Drugs (Volume) by Application

3 United States Oral Antidiabetic Drugs (Volume, Value and Sales Price)
3.1 United States Oral Antidiabetic Drugs Sales and Value (2013-2018)
3.1.1 United States Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
3.1.2 United States Oral Antidiabetic Drugs Revenue and Growth Rate (2013-2018)
3.1.3 United States Oral Antidiabetic Drugs Sales Price Trend (2013-2018)
3.2 United States Oral Antidiabetic Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Oral Antidiabetic Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Oral Antidiabetic Drugs Sales Volume and Market Share by Application (2013-2018)

4 Europe Oral Antidiabetic Drugs (Volume, Value and Sales Price)
4.1 Europe Oral Antidiabetic Drugs Sales and Value (2013-2018)
4.1.1 Europe Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
4.1.2 Europe Oral Antidiabetic Drugs Revenue and Growth Rate (2013-2018)
4.1.3 Europe Oral Antidiabetic Drugs Sales Price Trend (2013-2018)
4.2 Europe Oral Antidiabetic Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Oral Antidiabetic Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Oral Antidiabetic Drugs Sales Volume and Market Share by Application (2013-2018)

5 China Oral Antidiabetic Drugs (Volume, Value and Sales Price)
5.1 China Oral Antidiabetic Drugs Sales and Value (2013-2018)
5.1.1 China Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
5.1.2 China Oral Antidiabetic Drugs Revenue and Growth Rate (2013-2018)
5.1.3 China Oral Antidiabetic Drugs Sales Price Trend (2013-2018)
5.2 China Oral Antidiabetic Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Oral Antidiabetic Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Oral Antidiabetic Drugs Sales Volume and Market Share by Application (2013-2018)

6 Japan Oral Antidiabetic Drugs (Volume, Value and Sales Price)
6.1 Japan Oral Antidiabetic Drugs Sales and Value (2013-2018)
6.1.1 Japan Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
6.1.2 Japan Oral Antidiabetic Drugs Revenue and Growth Rate (2013-2018)
6.1.3 Japan Oral Antidiabetic Drugs Sales Price Trend (2013-2018)
6.2 Japan Oral Antidiabetic Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Oral Antidiabetic Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Oral Antidiabetic Drugs Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Oral Antidiabetic Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Oral Antidiabetic Drugs Sales and Value (2013-2018)
7.1.1 Southeast Asia Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Oral Antidiabetic Drugs Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Oral Antidiabetic Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Oral Antidiabetic Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Oral Antidiabetic Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Oral Antidiabetic Drugs Sales Volume and Market Share by Application (2013-2018)

8 India Oral Antidiabetic Drugs (Volume, Value and Sales Price)
8.1 India Oral Antidiabetic Drugs Sales and Value (2013-2018)
8.1.1 India Oral Antidiabetic Drugs Sales and Growth Rate (2013-2018)
8.1.2 India Oral Antidiabetic Drugs Revenue and Growth Rate (2013-2018)
8.1.3 India Oral Antidiabetic Drugs Sales Price Trend (2013-2018)
8.2 India Oral Antidiabetic Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Oral Antidiabetic Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Oral Antidiabetic Drugs Sales Volume and Market Share by Application (2013-2018)

9 Global Oral Antidiabetic Drugs Players/Suppliers Profiles and Sales Data
9.1 Eli Lilly
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Eli Lilly Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Merck
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Merck Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Pfizer
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Pfizer Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Abbott
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Abbott Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Biocon
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Biocon Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Sanofi
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Sanofi Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Sunpharma
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Sunpharma Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Novartis
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Novartis Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Novo Nordisk
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Novo Nordisk Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Boehringer Ingelheim
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Oral Antidiabetic Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Boehringer Ingelheim Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Takeda Pharmaceuticals
9.12 Oramed Pharmaceuticals
9.13 Jiangsu Wanbang
9.14 Nanjing Xinbai

10 Oral Antidiabetic Drugs Maufacturing Cost Analysis
10.1 Oral Antidiabetic Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Oral Antidiabetic Drugs
10.3 Manufacturing Process Analysis of Oral Antidiabetic Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Oral Antidiabetic Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Oral Antidiabetic Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Oral Antidiabetic Drugs Market Forecast (2018-2025)
14.1 Global Oral Antidiabetic Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Oral Antidiabetic Drugs Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Oral Antidiabetic Drugs Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Oral Antidiabetic Drugs Price and Trend Forecast (2018-2025)
14.2 Global Oral Antidiabetic Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Oral Antidiabetic Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Oral Antidiabetic Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Oral Antidiabetic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Oral Antidiabetic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Oral Antidiabetic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Oral Antidiabetic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Oral Antidiabetic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Oral Antidiabetic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Oral Antidiabetic Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Oral Antidiabetic Drugs Sales Forecast by Type (2018-2025)
14.3.2 Global Oral Antidiabetic Drugs Revenue Forecast by Type (2018-2025)
14.3.3 Global Oral Antidiabetic Drugs Price Forecast by Type (2018-2025)
14.4 Global Oral Antidiabetic Drugs Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Oral Antidiabetic Drugs
Figure Global Oral Antidiabetic Drugs Sales Volume Comparison (MT) by Type (2013-2025)
Figure Global Oral Antidiabetic Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Sulfonylureas Product Picture
Figure Biguanides Product Picture
Figure Meglitinides Product Picture
Figure Alpha-glucosidase Inhibitors Product Picture
Figure Others Product Picture
Figure Global Oral Antidiabetic Drugs Sales Comparison (MT) by Application (2013-2025)
Figure Global Sales Market Share of Oral Antidiabetic Drugs by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Oral Antidiabetic Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Oral Antidiabetic Drugs Sales Volume (MT) and Growth Rate (2013-2025)
Figure Global Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Oral Antidiabetic Drugs Sales Volume (MT) (2013-2018)
Table Global Oral Antidiabetic Drugs Sales (MT) of Key Players/Suppliers (2013-2018)
Table Global Oral Antidiabetic Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Oral Antidiabetic Drugs Sales Share by Players/Suppliers
Figure 2017 Oral Antidiabetic Drugs Sales Share by Players/Suppliers
Figure Global Oral Antidiabetic Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Oral Antidiabetic Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Oral Antidiabetic Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Oral Antidiabetic Drugs Revenue Share by Players
Table 2017 Global Oral Antidiabetic Drugs Revenue Share by Players
Table Global Oral Antidiabetic Drugs Sales (MT) and Market Share by Type (2013-2018)
Table Global Oral Antidiabetic Drugs Sales Share (MT) by Type (2013-2018)
Figure Sales Market Share of Oral Antidiabetic Drugs by Type (2013-2018)
Figure Global Oral Antidiabetic Drugs Sales Growth Rate by Type (2013-2018)
Table Global Oral Antidiabetic Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Oral Antidiabetic Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Oral Antidiabetic Drugs by Type (2013-2018)
Figure Global Oral Antidiabetic Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Oral Antidiabetic Drugs Sales Volume (MT) and Market Share by Region (2013-2018)
Table Global Oral Antidiabetic Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Oral Antidiabetic Drugs by Region (2013-2018)
Figure Global Oral Antidiabetic Drugs Sales Growth Rate by Region in 2017
Table Global Oral Antidiabetic Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Oral Antidiabetic Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Oral Antidiabetic Drugs by Region (2013-2018)
Figure Global Oral Antidiabetic Drugs Revenue Growth Rate by Region in 2017
Table Global Oral Antidiabetic Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Oral Antidiabetic Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Oral Antidiabetic Drugs by Region (2013-2018)
Figure Global Oral Antidiabetic Drugs Revenue Market Share by Region in 2017
Table Global Oral Antidiabetic Drugs Sales Volume (MT) and Market Share by Application (2013-2018)
Table Global Oral Antidiabetic Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Oral Antidiabetic Drugs by Application (2013-2018)
Figure Global Oral Antidiabetic Drugs Sales Market Share by Application (2013-2018)
Figure United States Oral Antidiabetic Drugs Sales (MT) and Growth Rate (2013-2018)
Figure United States Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Oral Antidiabetic Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table United States Oral Antidiabetic Drugs Sales Volume (MT) by Players (2013-2018)
Table United States Oral Antidiabetic Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Oral Antidiabetic Drugs Sales Volume Market Share by Players in 2017
Table United States Oral Antidiabetic Drugs Sales Volume (MT) by Type (2013-2018)
Table United States Oral Antidiabetic Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Oral Antidiabetic Drugs Sales Volume Market Share by Type in 2017
Table United States Oral Antidiabetic Drugs Sales Volume (MT) by Application (2013-2018)
Table United States Oral Antidiabetic Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Oral Antidiabetic Drugs Sales Volume Market Share by Application in 2017
Figure Europe Oral Antidiabetic Drugs Sales (MT) and Growth Rate (2013-2018)
Figure Europe Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Oral Antidiabetic Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table Europe Oral Antidiabetic Drugs Sales Volume (MT) by Players (2013-2018)
Table Europe Oral Antidiabetic Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Oral Antidiabetic Drugs Sales Volume Market Share by Players in 2017
Table Europe Oral Antidiabetic Drugs Sales Volume (MT) by Type (2013-2018)
Table Europe Oral Antidiabetic Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Oral Antidiabetic Drugs Sales Volume Market Share by Type in 2017
Table Europe Oral Antidiabetic Drugs Sales Volume (MT) by Application (2013-2018)
Table Europe Oral Antidiabetic Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Oral Antidiabetic Drugs Sales Volume Market Share by Application in 2017
Figure China Oral Antidiabetic Drugs Sales (MT) and Growth Rate (2013-2018)
Figure China Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Oral Antidiabetic Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table China Oral Antidiabetic Drugs Sales Volume (MT) by Players (2013-2018)
Table China Oral Antidiabetic Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Oral Antidiabetic Drugs Sales Volume Market Share by Players in 2017
Table China Oral Antidiabetic Drugs Sales Volume (MT) by Type (2013-2018)
Table China Oral Antidiabetic Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Oral Antidiabetic Drugs Sales Volume Market Share by Type in 2017
Table China Oral Antidiabetic Drugs Sales Volume (MT) by Application (2013-2018)
Table China Oral Antidiabetic Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Oral Antidiabetic Drugs Sales Volume Market Share by Application in 2017
Figure Japan Oral Antidiabetic Drugs Sales (MT) and Growth Rate (2013-2018)
Figure Japan Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Oral Antidiabetic Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table Japan Oral Antidiabetic Drugs Sales Volume (MT) by Players (2013-2018)
Table Japan Oral Antidiabetic Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Oral Antidiabetic Drugs Sales Volume Market Share by Players in 2017
Table Japan Oral Antidiabetic Drugs Sales Volume (MT) by Type (2013-2018)
Table Japan Oral Antidiabetic Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Oral Antidiabetic Drugs Sales Volume Market Share by Type in 2017
Table Japan Oral Antidiabetic Drugs Sales Volume (MT) by Application (2013-2018)
Table Japan Oral Antidiabetic Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Oral Antidiabetic Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Oral Antidiabetic Drugs Sales (MT) and Growth Rate (2013-2018)
Figure Southeast Asia Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Oral Antidiabetic Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table Southeast Asia Oral Antidiabetic Drugs Sales Volume (MT) by Players (2013-2018)
Table Southeast Asia Oral Antidiabetic Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Oral Antidiabetic Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Oral Antidiabetic Drugs Sales Volume (MT) by Type (2013-2018)
Table Southeast Asia Oral Antidiabetic Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Oral Antidiabetic Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Oral Antidiabetic Drugs Sales Volume (MT) by Application (2013-2018)
Table Southeast Asia Oral Antidiabetic Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Oral Antidiabetic Drugs Sales Volume Market Share by Application in 2017
Figure India Oral Antidiabetic Drugs Sales (MT) and Growth Rate (2013-2018)
Figure India Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Oral Antidiabetic Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table India Oral Antidiabetic Drugs Sales Volume (MT) by Players (2013-2018)
Table India Oral Antidiabetic Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Oral Antidiabetic Drugs Sales Volume Market Share by Players in 2017
Table India Oral Antidiabetic Drugs Sales Volume (MT) by Type (2013-2018)
Table India Oral Antidiabetic Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Oral Antidiabetic Drugs Sales Volume Market Share by Type in 2017
Table India Oral Antidiabetic Drugs Sales Volume (MT) by Application (2013-2018)
Table India Oral Antidiabetic Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Oral Antidiabetic Drugs Sales Volume Market Share by Application in 2017
Table Eli Lilly Basic Information List
Table Eli Lilly Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Eli Lilly Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly Oral Antidiabetic Drugs Sales Global Market Share (2013-2018)
Figure Eli Lilly Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Merck Basic Information List
Table Merck Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Merck Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Merck Oral Antidiabetic Drugs Sales Global Market Share (2013-2018)
Figure Merck Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Pfizer Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Oral Antidiabetic Drugs Sales Global Market Share (2013-2018
Figure Pfizer Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Abbott Basic Information List
Table Abbott Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Abbott Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Abbott Oral Antidiabetic Drugs Sales Global Market Share (2013-2018)
Figure Abbott Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Biocon Basic Information List
Table Biocon Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Biocon Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Biocon Oral Antidiabetic Drugs Sales Global Market Share (2013-2018)
Figure Biocon Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Sanofi Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Oral Antidiabetic Drugs Sales Global Market Share (2013-2018
Figure Sanofi Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Sunpharma Basic Information List
Table Sunpharma Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Sunpharma Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Sunpharma Oral Antidiabetic Drugs Sales Global Market Share (2013-2018)
Figure Sunpharma Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Novartis Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Novartis Oral Antidiabetic Drugs Sales Global Market Share (2013-2018
Figure Novartis Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Novo Nordisk Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Novo Nordisk Oral Antidiabetic Drugs Sales Global Market Share (2013-2018)
Figure Novo Nordisk Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Oral Antidiabetic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Oral Antidiabetic Drugs Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Oral Antidiabetic Drugs Sales Global Market Share (2013-2018)
Figure Boehringer Ingelheim Oral Antidiabetic Drugs Revenue Global Market Share (2013-2018)
Table Takeda Pharmaceuticals Basic Information List
Table Oramed Pharmaceuticals Basic Information List
Table Jiangsu Wanbang Basic Information List
Table Nanjing Xinbai Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Antidiabetic Drugs
Figure Manufacturing Process Analysis of Oral Antidiabetic Drugs
Figure Oral Antidiabetic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oral Antidiabetic Drugs Major Players in 2017
Table Major Buyers of Oral Antidiabetic Drugs
Table Distributors/Traders List
Figure Global Oral Antidiabetic Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Global Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Oral Antidiabetic Drugs Price (USD/Kg) and Trend Forecast (2018-2025)
Table Global Oral Antidiabetic Drugs Sales Volume (MT) Forecast by Regions (2018-2025)
Figure Global Oral Antidiabetic Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Oral Antidiabetic Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Oral Antidiabetic Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Oral Antidiabetic Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Oral Antidiabetic Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Oral Antidiabetic Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure United States Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Oral Antidiabetic Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Europe Oral Antidiabetic Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Oral Antidiabetic Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure China Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Oral Antidiabetic Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Japan Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Oral Antidiabetic Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Oral Antidiabetic Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure India Oral Antidiabetic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Oral Antidiabetic Drugs Sales (MT) Forecast by Type (2018-2025)
Figure Global Oral Antidiabetic Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Oral Antidiabetic Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Oral Antidiabetic Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Oral Antidiabetic Drugs Price (USD/Kg) Forecast by Type (2018-2025)
Table Global Oral Antidiabetic Drugs Sales (MT) Forecast by Application (2018-2025)
Figure Global Oral Antidiabetic Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

経口抗糖尿病薬、スルホニルウレア、ビグアニド、メグリチニド、α-グルコシダーゼ阻害剤、病院、診療所

★調査レポート[経口抗糖尿病薬の世界市場:販売動向2018] (コード:QYR80709699)販売に関する免責事項を必ずご確認ください。
★調査レポート[経口抗糖尿病薬の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆